We detected multiple genomic HBV integrations in two distinct types of liver cancer, with recurrent events at TERT, ZMAT4, MET, ANKFN1, PLXNB2 in ICC, and TERT, ALKBH5 in CHC. The gene discussed is ALKBH5; the disease is intrahepatic cholangiocarcinoma.